Mashhad University of Medical Sciences
mums.ac.irLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
91
Active
2
Phase 3
23
Total enrollment
5,733
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Platelet-Rich Plasma-Fibrin Glue | — | — | — | — | — | 1 | |
| Repairing Gel | — | — | — | — | — | 1 | |
| Repairing Gel and Platelet-Rich Plasma-Fibrin Glue | — | — | — | — | — | 1 |
Next readouts
- 2024-01-20
Top conditions
- Diabetic Foot Ulcers2
- Diabetic Wound2
- Pain2
- Pregnancy2
- Labor Pain2
- Oral Lichen Planus2
- Educational Course1
- Atrophy of Edentulous Alveolar Ridge1
Frequently asked questions about Mashhad University of Medical Sciences
- How many clinical trials does Mashhad University of Medical Sciences have on ClinicalTrials.gov?
- Mashhad University of Medical Sciences is listed as the lead sponsor on 91 clinical trials in ClinicalTrials.gov, 2 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Mashhad University of Medical Sciences's trials are in Phase 3?
- 23 of Mashhad University of Medical Sciences's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Mashhad University of Medical Sciences focus on?
- Mashhad University of Medical Sciences's most-studied conditions on ClinicalTrials.gov are Diabetic Foot Ulcers, Diabetic Wound, Pain, Pregnancy, Labor Pain.
- When are Mashhad University of Medical Sciences's next clinical trial readouts?
- Mashhad University of Medical Sciences has 1 upcoming primary-completion readout tracked here; the soonest is “Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care”, expected around 2024-01-20.